Role of IL-10 promoter polymorphisms in the development of severe aorto-iliac occlusive disease

Human Immunology

Volumn 69, Issue 10, 2008, Pages 651-654

  Blanco, Estrella ^a   Moñux, Guillermo ^b   Mas, Ana ^b   Serrano, Francisco J ^b   de la Concha, Emilio G ^b   Urcelay, Elena ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Gene polymorphism; Interleukin 10; Peripheral artery occlusive disease; Susceptibility

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HAPLOTYPE; HUMAN; LERICHE SYNDROME; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ARTERIAL OCCLUSIVE DISEASES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HETEROZYGOTE; HUMANS; INTERLEUKIN-10; MALE; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 54549118133     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.07.005     Document Type: Article

References (24)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115
2. van der Wal A.C., Becker A.E., van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36
3. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683
4. Mallat Z., Heymes C., Ohan J., Faggin E., Leseche G., and Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 19 (1999) 611
5. Pinderski L.J., Fischbein M.P., Subbanagounder G., Fishbein M.C., Kubo N., Cheroutre H., et al. Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes. Circ Res 90 (2002) 1064
6. Cohen S.B., Crawley J.B., Kahan M.C., Feldmann M., and Foxwell B.M. Interleukin-10 rescues T cells from apoptotic cell death: Association with an upregulation of Bcl-2. Immunology 92 (1997) 1
7. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 85 (1999) e17
8. Wojakowski W., Maslankiewicz K., Ochala A., Wyderka R., Zuk-Popiolek I., Flak Z., et al. The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina. Int J Mol Med 14 (2004) 317
9. Seljeflot I., Hurlen M., Solheim S., and Arnesen H. Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction. J Thromb Haemost 2 (2004) 350
10. Eskdale J., Kube D., Tesch H., and Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 46 (1997) 120
11. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in theinterleukin-10 gene promoter. Eur J Immunogenet 24 1 (1997) 1
12. Crawley E., Kay R., Sillibourne J., Patel P., Hutchinson I., and Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42 (1999) 1101
13. Eskdale J., Gallagher G., Verweij C.L., Keijsers V., Westendorp R.G., and Huizinga T.W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 95 (1998) 9465
14. Eskdale J., Keijsers V., Huizinga T., and Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1 (1999) 151
15. Cavet J., Middleton P.G., Segall M., Noreen H., Davies S.M., and Dickinson A.M. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94 (1999) 3941
16. Lio D., Candore G., Crivello A., Scola L., Colonna-Romano G., Cavallone L., et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: Genetic background of male centenarians is protective against coronary heart disease. J Med Genet 41 (2004) 790
17. Fei G.Z., Svenungsson E., Frostegard J., and Padyukov L. The A-1087IL-10 allele is associated with cardiovascular disease in SLE. Atherosclerosis 177 (2004) 409
18. Kahraman S., Yilmaz R., Arici M., Altun B., Erdem Y., Yasavul U., et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 19 1 (2006) 50
19. Trompet S., Pons D., AJ D.E.C., Slagboom P., Shepherd J., Blauw G.J., et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: The PROSPER study. Ann N Y Acad Sci 1100 (2007) 189
20. Donger C., Georges J.L., Nicaud V., Morrison C., Evans A., Kee F., et al. New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 31 (2001) 9
21. Koch W., Tiroch K., von Beckerath N., Schomig A., and Kastrati A. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine 24 (2003) 161
22. Oda K., Tanaka N., Arai T., Araki J., Song Y., Zhang L., et al. Polymorphisms in pro- and anti-inflammatory cytokine genes and susceptibility to atherosclerosis: A pathological study of 1503 consecutive autopsy cases. Hum Mol Genet 16 (2007) 592
23. Opdal S.H. IL-10 gene polymorphisms in infectious disease and SIDS. [Review]. FEMS Immunol Med Microbiol 42 (2004) 48
24. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 7145 (2007) 661